Showing 65,041 - 65,060 results of 122,056 for search '(( 2 d decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.11s Refine Results
  1. 65041

    image7_Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.jpeg by Mengxi Wang (231051)

    Published 2021
    “…The “risk of bias” evaluation tool in the Cochrane Handbook was used to evaluate the quality of the included studies. RevMan 5.3 software was used for meta-analysis.</p><p>Results: Eight studies meeting the criteria were included, with a total of 895 patients. …”
  2. 65042

    image1_Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.jpeg by Mengxi Wang (231051)

    Published 2021
    “…The “risk of bias” evaluation tool in the Cochrane Handbook was used to evaluate the quality of the included studies. RevMan 5.3 software was used for meta-analysis.</p><p>Results: Eight studies meeting the criteria were included, with a total of 895 patients. …”
  3. 65043

    image2_Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.jpeg by Mengxi Wang (231051)

    Published 2021
    “…The “risk of bias” evaluation tool in the Cochrane Handbook was used to evaluate the quality of the included studies. RevMan 5.3 software was used for meta-analysis.</p><p>Results: Eight studies meeting the criteria were included, with a total of 895 patients. …”
  4. 65044

    image8_Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.jpeg by Mengxi Wang (231051)

    Published 2021
    “…The “risk of bias” evaluation tool in the Cochrane Handbook was used to evaluate the quality of the included studies. RevMan 5.3 software was used for meta-analysis.</p><p>Results: Eight studies meeting the criteria were included, with a total of 895 patients. …”
  5. 65045

    image3_Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.jpeg by Mengxi Wang (231051)

    Published 2021
    “…The “risk of bias” evaluation tool in the Cochrane Handbook was used to evaluate the quality of the included studies. RevMan 5.3 software was used for meta-analysis.</p><p>Results: Eight studies meeting the criteria were included, with a total of 895 patients. …”
  6. 65046

    Table 1_Effects of different reduction patterns on stress distribution in patients with intertrochanteric fractures with intramedullary nail fixation: a finite element analysis.xls... by Jiajing Zhu (5117738)

    Published 2025
    “…</p>Results<p>As the head–neck fragment moved forward, the von Mises stress at the fracture surface, the proximal intersection point of the intramedullary nail, and the distal intersection point gradually decreased. This resulted in reduced fracture displacement, a significant decrease in trabecular bone volume, and a slight increase in the risk of screw cut-out. …”
  7. 65047
  8. 65048
  9. 65049
  10. 65050

    Effect of Strength Training on Oxidative Stress and the Correlation of the Same with Forearm Vasodilatation and Blood Pressure of Hypertensive Elderly Women: A Randomized Clinical... by Filipe Fernandes Oliveira Dantas (2967354)

    Published 2016
    “…The strength training group increased basal vascular conductance (VC) (pre: 3.56 ±0.88 units vs post: 5.21 ±1.28 units; <i>p</i> = 0.001; CI-95%: 0.93–2.38 units) and decreased basal MBP (pre: 93.1 ±6.3 mmHg vs post: 88.9 ±5.4 mmHg; <i>p</i> = 0.035; CI-95%: -8.0 –-0.4 mmHg). …”
  11. 65051

    The Synthesis, Structural, and Spectroscopic Characterization of Uranium(IV) Perrhenate Complexes by Gordon H. John (2667385)

    Published 2005
    “…In the case of compounds <b>5</b> and <b>6</b>, the coordination of eight ligands to the U<sup>IV</sup> center is completed by the binding of a solvent molecule (CH<sub>3</sub>CN) and OH<sup>-</sup>, respectively. …”
  12. 65052

    The Synthesis, Structural, and Spectroscopic Characterization of Uranium(IV) Perrhenate Complexes by Gordon H. John (2667385)

    Published 2005
    “…In the case of compounds <b>5</b> and <b>6</b>, the coordination of eight ligands to the U<sup>IV</sup> center is completed by the binding of a solvent molecule (CH<sub>3</sub>CN) and OH<sup>-</sup>, respectively. …”
  13. 65053

    The Synthesis, Structural, and Spectroscopic Characterization of Uranium(IV) Perrhenate Complexes by Gordon H. John (2667385)

    Published 2005
    “…In the case of compounds <b>5</b> and <b>6</b>, the coordination of eight ligands to the U<sup>IV</sup> center is completed by the binding of a solvent molecule (CH<sub>3</sub>CN) and OH<sup>-</sup>, respectively. …”
  14. 65054

    The Synthesis, Structural, and Spectroscopic Characterization of Uranium(IV) Perrhenate Complexes by Gordon H. John (2667385)

    Published 2005
    “…In the case of compounds <b>5</b> and <b>6</b>, the coordination of eight ligands to the U<sup>IV</sup> center is completed by the binding of a solvent molecule (CH<sub>3</sub>CN) and OH<sup>-</sup>, respectively. …”
  15. 65055

    Supplementary Material for: Long-term outcomes and clinical factors associated with conventional therapy failure in intestinal Behçet’s disease: A retrospective cohort study in Jap... by figshare admin karger (2628495)

    Published 2025
    “…Concomitant glucocorticoid use significantly decreased from 12.7±11.7 mg/day at baseline to 2.4±2.5 mg/day at 1 year (p<0.001). …”
  16. 65056

    Membrane currents and evoked calcium transients. by Saju Balakrishnan (58265)

    Published 2018
    “…<p><b><i>A</i>–</b>Sample HCN and calcium currents evoked by voltage steps to -50 and -110 mV, respectively, from the holding potential -70 mV, close to the measured resting potential. …”
  17. 65057

    Table_6_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  18. 65058

    Table_3_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  19. 65059

    Table_2_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  20. 65060

    Table_1_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.docx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”